Skip to main content

Table 3 Univariate analysis for risk factors of PCs in LAG

From: Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer

 

All

Abdominal

Non-abdominal

n

n (%)

p

n (%)

p

n (%)

p

Gender

male

380

71 (18.7)

0.027

53 (13.9)

0.10

27 (7.1)

0.023

 

female

149

16 (10.7)

 

13 (10.8)

 

3 (2.0)

 

Age

≥75

117

34(29.0)

<0.001

27 (23.1)

<0.001

12 (11.4)

0.015

 

<75

412

53 (12.9)

 

39 (9.5)

 

18 (4.4)

 

Body mass index

≥25 (kg/m2)

136

18 (13.2)

0.24

15 (11.0)

0.55

6 (4.4)

0.46

 

<25

393

69 (17.6)

 

51 (13.0)

 

24 (6.1)

 

Heart disease

yes

50

18 (36.0)

<0.001

13 (26.0)

0.002

10 (20.0)

<0.001

 

no

479

69 (14.4)

 

53 (11.1)

 

20 (4.1)

 

CNS disease

yes

39

13 (33.3)

0.003

10 (25.6)

0.020

7 (17.9)

0.004

 

no

490

74 (15.1)

 

56 (11.4)

 

23 (4.7)

 

Liver disease

yes

21

8 (38.1)

0.013

8 (38.1

<0.001

2 (9.5)

0.34

 

no

508

79 (15.6)

 

58 (11.4)

 

28 (5.5)

 

Diabetes mellitus

yes

67

12 (17.9)

0.73

10 (14.9)

0.52

5 (7.5)

0.57

 

no

462

75 (16.2)

 

56 (12.1)

 

25 (5.4)

 

Hypertension

yes

184

34 (18.5)

0.36

25 (13.6

0.57

13 (7.1)

0.31

 

no

345

53 (15.4)

 

41 (11.9)

 

17 (4.9)

 

Renal dysfunction

yes

54

17 (31.5)

0.002

14 (25.9)

0.002

6 (11.1)

0.11

 

no

475

70 (14.7)

 

52 (12.3)

 

24 (5.1)

 

Restrictive pulmonary dysfunction

yes

25

10 (40.0)

0.003

7 (28.0)

0.026

6 (24.0)

0.001

 

no

498

75 (15.0)

 

58 (13.2)

 

23 (4.6)

 
 

not evaluated

6

2

 

1

 

1

 

COPD

yes

112

17 (15.2)

0.73

11 (9.8)

0.35

8 (7.1)

0.41

 

no

411

68 (16.5)

 

54 (13.1)

 

21 (5.1)

 
 

not evaluated

6

2

 

1

 

1

 

Anemia

yes

131

29 (22.1)

0.043

22 (16.8)

0.085

12 (9.2)

0.047

 

no

398

58 (14.6)

 

44 (11.1)

 

18 (4.5)

 

Hypoalbuminemia

yes

8

3 (37.5)

0.13

2 (25.0)

0.26

2 (25.0)

0.071

 

no

519

84 (16.2)

 

64 (12.3)

 

28 (5.4)

 
 

not evaluated

2

0

 

0

 

0

 

Regular use of steroid

yes

9

4 (44.4)

0.045

2 (22.2)

0.31

2 (22.2)

0.087

 

no

520

83 (16.0)

 

64 (12.3)

 

28 (5.4)

 

Type of resection

total or proximal

112

29 (25.9)

0.002

20 (17.9)

0.052

13 (11.6)

0.002

 

distal

417

58 (13.9)

 

46 (12.4)

 

17(4.1)

 

Extent of lymph node dissection

D2

77

15 (19.5)

0.44

10 (13.0)

0.88

5 (6.5)

0.79

 

D1+ or D1

452

72 (15.9)

 

56 (12.4)

 

25 (5.5)

 

Combined resection

yes

16

6 (37.5)

0.033

4 (25.0)

0.13

2 (12.5)

0.23

 

no or gallbladder

513

81 (15.8)

 

62 (12.1)

 

28 (5.5)

 

Operating time

≥300 (min)

253

52 (20.6)

0.015

39 (15.4)

0.050

19 (7.5)

0.080

 

<300

276

35 (12.7)

 

27 (9.8)

 

11 (4.0)

 

Estimated bleeding

≥500(g)

43

12 (27.9)

0.031

10 (23.3)

0.026

4 (9.3)

0.28

 

<500

485

74 (15.2)

 

56 (11.5)

 

25 (5.2)

 
 

unknown

1

1

 

0

 

1